Parkinson's & Movement disorders

Sensor array may detect de novo Parkinson's disease in breath

(HealthDay)—A sensor array has the potential to identify de novo Parkinson's disease (PD) patients with high sensitivity, specificity, and accuracy values, according to a research letter published online July 10 in ACS ...

Parkinson's & Movement disorders

Progression of Parkinson's disease follows brain connectivity

A study by a group of researchers including those from The Montreal Neurological Institute and Hospital of McGill University has tested the theory that brain degeneration in Parkinson's disease (PD) originates in subcortical ...

Parkinson's & Movement disorders

Cognitive status doesn't impact cortical A-beta, tau in Parkinson's

(HealthDay)—Patterns of cortical β-amyloid (Aβ) and tau are not different for patients with Parkinson's disease (PD) who are cognitively normal (PD-CN) or with mild cognitive impairment (MCI) and for healthy adults, according ...

Parkinson's & Movement disorders

Impaired white matter integrity for depression in Parkinson's

(HealthDay)—Parkinson's disease (PD) patients with depression have impaired white matter integrity, especially in the long contact fibers in the left hemisphere, according to a study published online Nov. 10 in CNS Neuroscience ...

Parkinson's & Movement disorders

Impulsivity in Parkinson's disease

Dopamine medications are effective in treating the motor symptoms of Parkinson's disease (PD), but dopamine agonists can trigger impulsive-compulsive behaviors (ICBs), such as compulsive gambling, eating or shopping, in a ...

Parkinson's & Movement disorders

Novel genetic mutation discovered in Parkinson's disease patient

Mutations in the human genome may be responsible for many diseases. In the case of Parkinson's disease (PD), five locations have been the subject of recent attention. Variants of one of these locations, ACMSD (aminocarboxymuconate ...

page 5 from 11